These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19815507)

  • 1. Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.
    Bieging KT; Amick AC; Longnecker R
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17945-50. PubMed ID: 19815507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Pathways of p27
    Sora RP; Ikeda M; Longnecker R
    mBio; 2019 Apr; 10(2):. PubMed ID: 30992353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis.
    Ikeda M; Hayes CK; Schaller SJ; Longnecker R
    Blood Adv; 2022 Jul; 6(14):4283-4296. PubMed ID: 35605249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis.
    Bultema R; Longnecker R; Swanson-Mungerson M
    Oncogene; 2009 Mar; 28(11):1471-6. PubMed ID: 19182823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A.
    Bieging KT; Swanson-Mungerson M; Amick AC; Longnecker R
    Cell Cycle; 2010 Mar; 9(5):901-8. PubMed ID: 20160479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma.
    Bieging KT; Fish K; Bondada S; Longnecker R
    Blood; 2011 Dec; 118(26):6849-59. PubMed ID: 22039254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.
    Cen O; Longnecker R
    Mol Cancer Ther; 2011 Apr; 10(4):679-86. PubMed ID: 21282357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in the pathogenesis of Burkitt's lymphoma.
    Zimber-Strobl U; Strobl L; Höfelmayr H; Kempkes B; Staege MS; Laux G; Christoph B; Polack A; Bornkamm GW
    Curr Top Microbiol Immunol; 1999; 246():315-20; discussion 321. PubMed ID: 10396071
    [No Abstract]   [Full Text] [Related]  

  • 9. Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.
    Dargart JL; Fish K; Gordon LI; Longnecker R; Cen O
    Antiviral Res; 2012 Jul; 95(1):49-56. PubMed ID: 22609829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
    Swanson-Mungerson M; Bultema R; Longnecker R
    J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Epstein-Barr virus in Burkitt's lymphoma.
    Takada K
    Curr Top Microbiol Immunol; 2001; 258():141-51. PubMed ID: 11443859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.
    Fish K; Chen J; Longnecker R
    Blood; 2014 Jan; 123(4):530-40. PubMed ID: 24174629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
    Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
    Kennedy G; Komano J; Sugden B
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14269-74. PubMed ID: 14603034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The curious case of the tumour virus: 50 years of Burkitt's lymphoma.
    Thorley-Lawson DA; Allday MJ
    Nat Rev Microbiol; 2008 Dec; 6(12):913-24. PubMed ID: 19008891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma.
    Cen O; Kannan K; Huck Sappal J; Yu J; Zhang M; Arikan M; Ucur A; Ustek D; Cen Y; Gordon L; Longnecker R
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of EBV and Ig/myc translocation in Burkitt lymphoma.
    Klein G
    Antibiot Chemother (1971); 1994; 46():110-6. PubMed ID: 7826031
    [No Abstract]   [Full Text] [Related]  

  • 19. Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma.
    Portis T; Dyck P; Longnecker R
    Blood; 2003 Dec; 102(12):4166-78. PubMed ID: 12907455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas.
    Incrocci R; McCormack M; Swanson-Mungerson M
    J Gen Virol; 2013 May; 94(Pt 5):1127-1133. PubMed ID: 23303827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.